Injections of stem cells for treating knee osteoarthritis
Official title: Allogenic Mesenchymal Stem Cell Intraarticular Injection for Knee Osteoarthritis Therapy, an RCT Explorative Mode-of-action Study
Run by Aarhus University Hospital · NCT05933434 · Data updated 2026-11-12
This study is testing if injections of stem cells can help people with mild to moderate knee osteoarthritis feel less pain and move better compared to a placebo injection.
Quick facts
| Phase | Phase1; Phase2 |
|---|---|
| Study type | Interventional |
| Ages | 40 Years to 75 Years |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | Aarhus University Hospital Academic / other |
| Locations | 1 site (Aarhus N) |
| Status | Recruiting |
| Started | March 7, 2024 |
| Main results expected | October 2030 |
| Study ends | October 2030 |
| Registry record updated | June 11, 2024 |
| Trial ID | NCT05933434 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are Danish-speaking adults with chronic knee pain and Grade II-III osteoarthritis.
✕Probably not a fit
Patients with severe osteoarthritis or those who have had recent knee injections or surgeries may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial evaluates the safety and effectiveness of injecting allogenic adipose-derived mesenchymal stem cells (AD-MSC) into the knee joint of patients with mild to moderate knee osteoarthritis. Participants will be randomly assigned to receive either the stem cell injection or a placebo saline injection. The study aims to determine if the stem cell treatment can alleviate chronic knee pain and improve joint function compared to the placebo. It is a double-blinded trial, ensuring that neither the participants nor the researchers know who receives which treatment.
Why it matters
Potential benefit: If successful, this treatment could provide a new, effective option for patients suffering from knee osteoarthritis, potentially reducing pain and improving mobility.
How similar studies have gone: Previous studies have shown promise in using stem cells for joint therapy, but this specific approach is still being evaluated for its efficacy.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Chronic knee pain (defined for at least 6 months with NRS 4 or above when pain worst) * Patients with Grade II-III osteoarthritis according to the Kellgren Lawrence Classification and a joint width space of 1-3 mm. * Axial hip, knee, ankle x-ray with no more than 5 degrees valgus/varus deformity * Medial, lateral or dual compartment OA as determined above * BMI \<35 * Danish speaker * Patients must be legally competent and must be able to sign the written consent Exclusion Criteria: * Severe Osteoarthritis (Grade IV according to Kellgren Lavrence Classification) * Intraarticular tumor, infection or fracture * Pregnancy and breast feeding * Cognitive impairment * Treatment with cytostatic drugs * Previous intraarticular knee injection in the past 3 mo. * Unable to perform MRI scan (non-compatible implants, claustrophobia and severe obesity(\>BMI 35) * Previous ligament reconstruction * Meniscal operation with resection with more than 50% or multiple meniscal operations (more than one resection) * Diabetes mellitus type 1 and 2 * Knee instability on physical examination * History of allergy to antibiotics * Concomitant severe infection, malignant tumor, coagulation diseases or uncontrolled or unmanaged systemic disease * Presence of other types of inflammatory arthritis
Where it's running
-
Aarhus University
Aarhus N, Denmark Recruiting
Study contacts
- Principal investigator: Rasmus Aabling, MD — University of Aarhus
- Study coordinator: Rasmus Aabling, MD
- Email: rasaab@clin.au.dk
- Phone: +4528496767
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effects of virtual reality on walking in adults with knee osteoarthritis
This study tests how immersive virtual reality environments—designed to feel safe or to provoke fear—affect walking and worry about movement in adults 50 and older with knee osteoarthritis and in healthy peers.
-
Weekly berobenatide for knee osteoarthritis in adults who are overweight or obese
This study tests whether weekly berobenatide helps reduce knee pain and improve function, while also affecting body weight, in adults with knee osteoarthritis who are overweight or obese (with or without type 2 diabetes).
-
Autologous adipose-derived stem cell injections for knee osteoarthritis
We’re testing whether injecting a patient’s own fat-derived stem cells into the knee can help people with knee OA feel less pain and move better, compared with a standard hyaluronic acid treatment.
-
Preoperative Multimorbidity and Functional Recovery After Total Knee Arthroplasty
This study tests whether higher burden of preoperative multimorbidity affects functional recovery after knee replacement in adults with knee osteoarthritis.
-
Cartilage biomarker response to acute loading in knee OA by antiresorptive treatment status
Researchers will test whether a 30-minute treadmill walk changes cartilage biomarkers in postmenopausal women with knee osteoarthritis, comparing those on denosumab, bisphosphonates, and those not on antiresorptives.
-
Lysyl Enzymes in Knee Osteoarthritis
This study tests whether blood levels of lysyl hydroxylase and lysyl oxidase differ between people with knee osteoarthritis and healthy individuals.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.